Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q3 2024.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $1.08M, a 33.8% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.08M -$548K -33.8% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.27M +$29K +2.33% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.18M -$303K -20.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.42M -$348K -19.7% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.62M -$596K -26.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.25M -$1.15M -48% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.48M -$1.57M -51.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.77M -$1.87M -51.4% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.22M -$284K -11.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.39M -$608K -20.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.05M -$437K -12.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.63M -$345K -8.67% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.5M -$1.9M -43.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3M +$1.03M +52.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.49M +$1.4M +66.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.98M +$1.75M +78.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $4.4M +$2.07M +88.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.97M -$514K -20.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.09M -$559K -21.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.23M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.34M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $2.48M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.65M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.